{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:59:01Z","timestamp":1791233941890,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eururo.2026.05.035","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:05:29Z","timestamp":1781323529000},"page":"137-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radical Prostatectomy in Low-volume Metastatic Prostate Cancer? The Need for New Evidence"],"prefix":"10.1016","volume":"90","author":[{"given":"Prasanna","family":"Sooriakumaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie C.","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.05.035_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1593\/tlo.08178","article-title":"Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments","volume":"1","author":"Pienta","year":"2008","journal-title":"Transl Oncol"},{"key":"10.1016\/j.eururo.2026.05.035_b0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1078-0432.CCR-22-2340","article-title":"Radiotherapy induces innate immune responses in patients treated for prostate cancers","volume":"29","author":"Cheema","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2026.05.035_b0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.eururo.2015.05.023","article-title":"A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation","volume":"69","author":"Sooriakumaran","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.035_b0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bju.15669","article-title":"Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing radical prostatectomy in men with prostate cancer and oligo-metastases to the bone (TRoMbone) trial","volume":"130","author":"Sooriakumaran","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2026.05.035_b0025","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2026.05.035_b0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2018.09.008","volume":"75","author":"Boev\u00e9","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.05.035_b0035","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(24)01865-8","article-title":"Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2\u00a0\u00d7\u00a02 factorial design","volume":"404","author":"Bossi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2026.05.035_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2026.02.011","article-title":"A phase 2, randomized, controlled trial of best systemic therapy versus best systemic therapy with definitive treatment of the primary tumor in metastatic prostate cancer","volume":"90","author":"Chapin","year":"2026","journal-title":"Eur Urol."},{"key":"10.1016\/j.eururo.2026.05.035_b0045","doi-asserted-by":"crossref","unstructured":"Graefen M, Falkenbach F, Maurer T, et al. Radical prostatectomy plus best systemic therapy versus best systemic therapy alone in oligometastatic prostate cancer: the RAMPP randomised controlled trial. Eur Urol 2026;90:116\u201324.","DOI":"10.1016\/j.eururo.2025.09.4144"},{"key":"10.1016\/j.eururo.2026.05.035_b0050","unstructured":"NIHR. PRostatEctomy Surgery In Disseminated metastatic hormone sensitive prostate cancer with Endpoint assessment using Nuclear imaging Technology using PSMA PET\/CT: a randomised controlled full trial (PRESIDENT). https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR172122."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382602213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382602213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:26:50Z","timestamp":1785886010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382602213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S030228382602213X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.05.035","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radical Prostatectomy in Low-volume Metastatic Prostate Cancer? The Need for New Evidence","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}